Formulation: A neat solid
Pricing updated 2019-03-21. Prices are subject to change without notice.
AB-FUBINACA (Item No. 14039) is an indazole-based synthetic cannabinoid (CB) with 10-fold greater affinity for the CB1 receptor (Ki = 0.9 nM) than that of JWH 018 (Item No. 10900).1,2
MDMB-FUBINACA is a derivative of AB-FUBINACA in which the terminal aminocarbonyl moiety is replaced by a methyl ester group and the isobutyl moiety is substituted with a tert-butyl group. The physiological and toxicological properties of this compound have not been determined. This product is intended for research and forensic applications.
This product is a qualified Reference Material (RM) that has been manufactured and tested to meet ISO17025 and Guide 34 guidelines. These materials are tested using validated analytical methods on qualified instrumentation to ensure traceability of measurements. All traceable RMs may be distinguished by their CofAs and can be downloaded below using the batch number located on the product label. For a representative CofA please contact our technical support.
Warning - this product is not for human or veterinary use.
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GC-MS spectra of many of Cayman's emerging forensic drug standards
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Uchiyama, N., Matsuda, S., Wakana, D., et al. New cannabimimetic indazole derivatives, N-
2. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives PCT/IB2009/000432, 1-283 (2009).